EU trade movers · 2025-04 · chapter 29
EU trade movers: April 2025, Organic chemicals
The largest month on month and year on year changes in the trade of each EU member state with each partner country, per HS4 product in chapter 29. Flows of at least EUR 5 million in April 2025; percent lists need at least EUR 1 million in the comparison month. Every figure carries its Eurostat record ID.
March 2025 · May 2025 · All chapters, April 2025 · Atom feed
Largest month on month changes, EUR
| # | Flow | Product | April 2025 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Ireland exports to United States | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 2.8 billion | EUR 15.6 billion 2025-03 | −EUR 12.9 billion | −82.2% | DS-045409:IE:US:2937:2:2025-04 DS-045409:IE:US:2937:2:2025-03 |
| 2 | Ireland exports to United States | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 75.6 million | EUR 1.7 billion 2025-03 | −EUR 1.6 billion | −95.5% | DS-045409:IE:US:2933:2:2025-04 DS-045409:IE:US:2933:2:2025-03 |
| 3 | Ireland exports to United States | 2934 Nucleic acids and their salts | EUR 989.6 million | EUR 2.2 billion 2025-03 | −EUR 1.3 billion | −56.0% | DS-045409:IE:US:2934:2:2025-04 DS-045409:IE:US:2934:2:2025-03 |
| 4 | Italy imports from United States | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 998.4 million | EUR 129.0 million 2025-03 | +EUR 869.4 million | +674.2% | DS-045409:IT:US:2937:1:2025-04 DS-045409:IT:US:2937:1:2025-03 |
| 5 | Ireland exports to Portugal | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 687.2 million | EUR 2.8 million 2025-03 | +EUR 684.3 million | +24,180.8% | DS-045409:IE:PT:2933:2:2025-04 DS-045409:IE:PT:2933:2:2025-03 |
| 6 | Portugal imports from Ireland | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 452.1 million | EUR 4.7 million 2025-03 | +EUR 447.4 million | +9,616.9% | DS-045409:PT:IE:2933:1:2025-04 DS-045409:PT:IE:2933:1:2025-03 |
| 7 | Slovenia imports from China | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 833.7 million | EUR 1.2 billion 2025-03 | −EUR 365.2 million | −30.5% | DS-045409:SI:CN:2933:1:2025-04 DS-045409:SI:CN:2933:1:2025-03 |
| 8 | Belgium exports to Germany | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 45.9 million | EUR 378.0 million 2025-03 | −EUR 332.1 million | −87.9% | DS-045409:BE:DE:2933:2:2025-04 DS-045409:BE:DE:2933:2:2025-03 |
| 9 | Germany imports from Belgium | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 54.6 million | EUR 355.6 million 2025-03 | −EUR 301.0 million | −84.6% | DS-045409:DE:BE:2933:1:2025-04 DS-045409:DE:BE:2933:1:2025-03 |
| 10 | Germany imports from Switzerland | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 487.2 million | EUR 191.3 million 2025-03 | +EUR 295.9 million | +154.7% | DS-045409:DE:CH:2933:1:2025-04 DS-045409:DE:CH:2933:1:2025-03 |
| 11 | Romania imports from Switzerland | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 191.4 million | EUR 2.7 million 2025-03 | +EUR 188.8 million | +7,096.3% | DS-045409:RO:CH:2933:1:2025-04 DS-045409:RO:CH:2933:1:2025-03 |
| 12 | Germany exports to United States | 2935 Sulphonamides | EUR 183.9 million | EUR 1.8 million 2025-03 | +EUR 182.1 million | +10,378.1% | DS-045409:DE:US:2935:2:2025-04 DS-045409:DE:US:2935:2:2025-03 |
| 13 | Ireland exports to Italy | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 216.6 million | EUR 386.1 million 2025-03 | −EUR 169.5 million | −43.9% | DS-045409:IE:IT:2937:2:2025-04 DS-045409:IE:IT:2937:2:2025-03 |
| 14 | Slovenia imports from India | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 585.8 million | EUR 431.0 million 2025-03 | +EUR 154.8 million | +35.9% | DS-045409:SI:IN:2933:1:2025-04 DS-045409:SI:IN:2933:1:2025-03 |
| 15 | Germany exports to Greece | 2932 Heterocyclic compounds with oxygen hetero-atom | EUR 27.4 million | EUR 154.6 million 2025-03 | −EUR 127.2 million | −82.3% | DS-045409:DE:GR:2932:2:2025-04 DS-045409:DE:GR:2932:2:2025-03 |
Largest month on month changes, percent
| # | Flow | Product | April 2025 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Ireland exports to Portugal | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 687.2 million | EUR 2.8 million 2025-03 | +EUR 684.3 million | +24,180.8% | DS-045409:IE:PT:2933:2:2025-04 DS-045409:IE:PT:2933:2:2025-03 |
| 2 | Germany exports to United States | 2935 Sulphonamides | EUR 183.9 million | EUR 1.8 million 2025-03 | +EUR 182.1 million | +10,378.1% | DS-045409:DE:US:2935:2:2025-04 DS-045409:DE:US:2935:2:2025-03 |
| 3 | Portugal imports from Ireland | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 452.1 million | EUR 4.7 million 2025-03 | +EUR 447.4 million | +9,616.9% | DS-045409:PT:IE:2933:1:2025-04 DS-045409:PT:IE:2933:1:2025-03 |
| 4 | Romania imports from Switzerland | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 191.4 million | EUR 2.7 million 2025-03 | +EUR 188.8 million | +7,096.3% | DS-045409:RO:CH:2933:1:2025-04 DS-045409:RO:CH:2933:1:2025-03 |
| 5 | Ireland exports to Portugal | 2934 Nucleic acids and their salts | EUR 40.7 million | EUR 1.1 million 2025-03 | +EUR 39.5 million | +3,547.2% | DS-045409:IE:PT:2934:2:2025-04 DS-045409:IE:PT:2934:2:2025-03 |
| 6 | Portugal imports from Ireland | 2934 Nucleic acids and their salts | EUR 39.8 million | EUR 1.2 million 2025-03 | +EUR 38.5 million | +3,102.8% | DS-045409:PT:IE:2934:1:2025-04 DS-045409:PT:IE:2934:1:2025-03 |
| 7 | Ireland imports from Singapore | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 65.7 million | EUR 2.5 million 2025-03 | +EUR 63.2 million | +2,513.7% | DS-045409:IE:SG:2933:1:2025-04 DS-045409:IE:SG:2933:1:2025-03 |
| 8 | Germany imports from Ireland | 2934 Nucleic acids and their salts | EUR 88.8 million | EUR 4.5 million 2025-03 | +EUR 84.3 million | +1,860.6% | DS-045409:DE:IE:2934:1:2025-04 DS-045409:DE:IE:2934:1:2025-03 |
| 9 | Ireland exports to Germany | 2934 Nucleic acids and their salts | EUR 89.1 million | EUR 4.6 million 2025-03 | +EUR 84.4 million | +1,816.2% | DS-045409:IE:DE:2934:2:2025-04 DS-045409:IE:DE:2934:2:2025-03 |
| 10 | Germany exports to United States | 2924 Carboxyamide-function compounds | EUR 32.6 million | EUR 1.9 million 2025-03 | +EUR 30.7 million | +1,625.2% | DS-045409:DE:US:2924:2:2025-04 DS-045409:DE:US:2924:2:2025-03 |
| 11 | Germany exports to United States | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 31.8 million | EUR 1.9 million 2025-03 | +EUR 29.9 million | +1,568.1% | DS-045409:DE:US:2937:2:2025-04 DS-045409:DE:US:2937:2:2025-03 |
| 12 | Austria imports from Japan | 2934 Nucleic acids and their salts | EUR 14.2 million | EUR 1.4 million 2025-03 | +EUR 12.9 million | +942.0% | DS-045409:AT:JP:2934:1:2025-04 DS-045409:AT:JP:2934:1:2025-03 |
| 13 | Cyprus imports from China | 2909 Ethers, ether-alcohols, ether-phenols, ether-alcohol-phenols | EUR 19.5 million | EUR 2.3 million 2025-03 | +EUR 17.3 million | +761.2% | DS-045409:CY:CN:2909:1:2025-04 DS-045409:CY:CN:2909:1:2025-03 |
| 14 | Italy imports from United States | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 998.4 million | EUR 129.0 million 2025-03 | +EUR 869.4 million | +674.2% | DS-045409:IT:US:2937:1:2025-04 DS-045409:IT:US:2937:1:2025-03 |
| 15 | Ireland imports from China | 2934 Nucleic acids and their salts | EUR 91.5 million | EUR 11.9 million 2025-03 | +EUR 79.6 million | +667.4% | DS-045409:IE:CN:2934:1:2025-04 DS-045409:IE:CN:2934:1:2025-03 |
Largest year on year changes, EUR
| # | Flow | Product | April 2025 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Ireland exports to United States | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 2.8 billion | EUR 311.3 million 2024-04 | +EUR 2.5 billion | +795.0% | DS-045409:IE:US:2937:2:2025-04 DS-045409:IE:US:2937:2:2024-04 |
| 2 | Italy imports from China | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 1.1 billion | EUR 13.7 million 2024-04 | +EUR 1.1 billion | +8,103.6% | DS-045409:IT:CN:2937:1:2025-04 DS-045409:IT:CN:2937:1:2024-04 |
| 3 | Ireland exports to United States | 2934 Nucleic acids and their salts | EUR 989.6 million | EUR 3.8 million 2024-04 | +EUR 985.8 million | +25,812.8% | DS-045409:IE:US:2934:2:2025-04 DS-045409:IE:US:2934:2:2024-04 |
| 4 | Italy imports from United States | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 998.4 million | EUR 91.2 million 2024-04 | +EUR 907.1 million | +994.2% | DS-045409:IT:US:2937:1:2025-04 DS-045409:IT:US:2937:1:2024-04 |
| 5 | Ireland exports to United States | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 75.6 million | EUR 833.5 million 2024-04 | −EUR 757.9 million | −90.9% | DS-045409:IE:US:2933:2:2025-04 DS-045409:IE:US:2933:2:2024-04 |
| 6 | Ireland exports to Portugal | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 687.2 million | EUR 940,187 2024-04 | +EUR 686.2 million | small base | DS-045409:IE:PT:2933:2:2025-04 DS-045409:IE:PT:2933:2:2024-04 |
| 7 | Germany imports from Ireland | 2934 Nucleic acids and their salts | EUR 88.8 million | EUR 663.4 million 2024-04 | −EUR 574.6 million | −86.6% | DS-045409:DE:IE:2934:1:2025-04 DS-045409:DE:IE:2934:1:2024-04 |
| 8 | Ireland exports to Germany | 2934 Nucleic acids and their salts | EUR 89.1 million | EUR 660.2 million 2024-04 | −EUR 571.1 million | −86.5% | DS-045409:IE:DE:2934:2:2025-04 DS-045409:IE:DE:2934:2:2024-04 |
| 9 | Belgium exports to Germany | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 45.9 million | EUR 515.9 million 2024-04 | −EUR 469.9 million | −91.1% | DS-045409:BE:DE:2933:2:2025-04 DS-045409:BE:DE:2933:2:2024-04 |
| 10 | Germany imports from Belgium | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 54.6 million | EUR 507.6 million 2024-04 | −EUR 452.9 million | −89.2% | DS-045409:DE:BE:2933:1:2025-04 DS-045409:DE:BE:2933:1:2024-04 |
| 11 | Portugal imports from Ireland | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 452.1 million | EUR 930,751 2024-04 | +EUR 451.2 million | small base | DS-045409:PT:IE:2933:1:2025-04 DS-045409:PT:IE:2933:1:2024-04 |
| 12 | Slovenia imports from China | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 833.7 million | EUR 517.3 million 2024-04 | +EUR 316.4 million | +61.2% | DS-045409:SI:CN:2933:1:2025-04 DS-045409:SI:CN:2933:1:2024-04 |
| 13 | Germany imports from Switzerland | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 487.2 million | EUR 189.4 million 2024-04 | +EUR 297.9 million | +157.3% | DS-045409:DE:CH:2933:1:2025-04 DS-045409:DE:CH:2933:1:2024-04 |
| 14 | Ireland imports from Switzerland | 2934 Nucleic acids and their salts | EUR 55.0 million | EUR 330.9 million 2024-04 | −EUR 275.9 million | −83.4% | DS-045409:IE:CH:2934:1:2025-04 DS-045409:IE:CH:2934:1:2024-04 |
| 15 | Slovenia imports from Switzerland | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 200.9 million | EUR 442.4 million 2024-04 | −EUR 241.5 million | −54.6% | DS-045409:SI:CH:2933:1:2025-04 DS-045409:SI:CH:2933:1:2024-04 |
Largest year on year changes, percent
| # | Flow | Product | April 2025 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Ireland exports to United States | 2934 Nucleic acids and their salts | EUR 989.6 million | EUR 3.8 million 2024-04 | +EUR 985.8 million | +25,812.8% | DS-045409:IE:US:2934:2:2025-04 DS-045409:IE:US:2934:2:2024-04 |
| 2 | Italy imports from China | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 1.1 billion | EUR 13.7 million 2024-04 | +EUR 1.1 billion | +8,103.6% | DS-045409:IT:CN:2937:1:2025-04 DS-045409:IT:CN:2937:1:2024-04 |
| 3 | Belgium imports from France | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 160.2 million | EUR 2.1 million 2024-04 | +EUR 158.1 million | +7,501.2% | DS-045409:BE:FR:2933:1:2025-04 DS-045409:BE:FR:2933:1:2024-04 |
| 4 | France exports to Belgium | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 151.2 million | EUR 3.5 million 2024-04 | +EUR 147.7 million | +4,167.1% | DS-045409:FR:BE:2933:2:2025-04 DS-045409:FR:BE:2933:2:2024-04 |
| 5 | Germany exports to United States | 2924 Carboxyamide-function compounds | EUR 32.6 million | EUR 2.4 million 2024-04 | +EUR 30.1 million | +1,230.2% | DS-045409:DE:US:2924:2:2025-04 DS-045409:DE:US:2924:2:2024-04 |
| 6 | Spain imports from United Kingdom | 2934 Nucleic acids and their salts | EUR 12.1 million | EUR 1.1 million 2024-04 | +EUR 11.0 million | +1,028.4% | DS-045409:ES:GB:2934:1:2025-04 DS-045409:ES:GB:2934:1:2024-04 |
| 7 | Italy imports from United States | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 998.4 million | EUR 91.2 million 2024-04 | +EUR 907.1 million | +994.2% | DS-045409:IT:US:2937:1:2025-04 DS-045409:IT:US:2937:1:2024-04 |
| 8 | Belgium exports to France | 2935 Sulphonamides | EUR 15.0 million | EUR 1.6 million 2024-04 | +EUR 13.4 million | +862.1% | DS-045409:BE:FR:2935:2:2025-04 DS-045409:BE:FR:2935:2:2024-04 |
| 9 | Romania imports from Switzerland | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 191.4 million | EUR 21.2 million 2024-04 | +EUR 170.2 million | +803.6% | DS-045409:RO:CH:2933:1:2025-04 DS-045409:RO:CH:2933:1:2024-04 |
| 10 | Ireland exports to United States | 2937 Hormones, prostaglandins, thromboxanes and leukotrienes | EUR 2.8 billion | EUR 311.3 million 2024-04 | +EUR 2.5 billion | +795.0% | DS-045409:IE:US:2937:2:2025-04 DS-045409:IE:US:2937:2:2024-04 |
| 11 | France imports from Japan | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 8.4 million | EUR 1.0 million 2024-04 | +EUR 7.3 million | +707.4% | DS-045409:FR:JP:2933:1:2025-04 DS-045409:FR:JP:2933:1:2024-04 |
| 12 | Spain imports from China | 2921 Amine-function compounds | EUR 16.2 million | EUR 2.4 million 2024-04 | +EUR 13.8 million | +578.5% | DS-045409:ES:CN:2921:1:2025-04 DS-045409:ES:CN:2921:1:2024-04 |
| 13 | Netherlands imports from United States | 2910 Epoxides, epoxyalcohols, epoxyphenols and epoxyethers | EUR 13.9 million | EUR 2.1 million 2024-04 | +EUR 11.9 million | +573.0% | DS-045409:NL:US:2910:1:2025-04 DS-045409:NL:US:2910:1:2024-04 |
| 14 | Ireland exports to Switzerland | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 16.9 million | EUR 2.6 million 2024-04 | +EUR 14.2 million | +539.1% | DS-045409:IE:CH:2933:2:2025-04 DS-045409:IE:CH:2933:2:2024-04 |
| 15 | Spain imports from Netherlands | 2933 Heterocyclic compounds with nitrogen hetero-atom | EUR 26.5 million | EUR 4.2 million 2024-04 | +EUR 22.3 million | +532.1% | DS-045409:ES:NL:2933:1:2025-04 DS-045409:ES:NL:2933:1:2024-04 |
Data Passport
- Eurostat Comext DS-045409: monthly trade of the EU member states by partner country and product, EUR and net mass, months 2025-03, 2025-04 and 2024-04. Licence: Eurostat reuse policy, free reuse with attribution "Source: Eurostat" (© European Union). Record IDs: DS-045409:reporter:partner:product:flow:month. Source
- Method: For each EU reporter, HS4 product, partner country and flow, the value of April 2025 is compared with the month before and with the same month a year earlier. A missing month row counts as no recorded trade. Lists rank by the absolute change in EUR or by the percent change; aggregates (world, intra and extra EU) and confidential partners are left out, as are Peru and the Philippines.
Trade database built 2026-10-24. Values are official statistics as published; nothing on this page is estimated or invented. More in our methodology.
See the companies
Members see the importers and exporters behind these flows, with their evidence and Data Passport.